Overview

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

Status:
Completed

Trial end date:
2011-06-29

Target enrollment:

Participant gender:

Summary

This study investigates the safety, pharmacokinetics and effects of GSK1292263 when taken alone or when co-dosed with atorvastatin to subjects with dyslipidemia.

Phase:

Phase 2

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Atorvastatin
Atorvastatin Calcium
Ezetimibe